Bicalutamide 50 mg daily is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D2 metastatic carcinoma of the prostate.

Bicalutamide 150 mg daily is not approved for use alone or with other treatments

Bical 50mg

  • Product Code: BMB7894614
  • Availability: In Stock
  • BDT 80.00
Add to Wish List Compare this Product

Tags: Bical